GeneNews Ltd (TSE:GEN – Get Free Report)’s share price rose 7.1% during mid-day trading on Monday . The company traded as high as C$0.15 and last traded at C$0.15. Approximately 473,147 shares were traded during mid-day trading, a decline of 68% from the average daily volume of 1,480,179 shares. The stock had previously closed at C$0.14.
GeneNews Stock Up 7.1 %
The stock has a market capitalization of C$25.49 million and a P/E ratio of -2.21. The stock’s 50-day moving average price is C$0.15.
About GeneNews
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Recommended Stories
- Five stocks we like better than GeneNews
- Best Aerospace Stocks Investing
- The Charles Schwab Company Can Hit New Highs
- What Are Dividends? Buy the Best Dividend Stocks
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.
